Spyre Therapeutics announces proposed public offering of common stock
SYRE•Spyre Therapeutics announced a proposed public offering of its common stock. It intends to use the net proceeds to advance its programs and the late-stage development of SPY072.
1. Offering plans
Spyre Therapeutics announced a proposed public offering of its common stock. The company intends to use the net proceeds to advance its programs and the late-stage development of SPY072.
